Table 4. Relationship between the changes in the values of PASI, CRP, NLR, and patients' characteristics.
| Changes in PASI value | Changes in CRP value | Changes in NLR value | |
|---|---|---|---|
| Sex | |||
| Female (n=39) | |||
| Min-max (med) | −0.8-31.7 (10) | −2.3-13.5 (0.4) | −1.4-1.7 (0.2) |
| Mean±SD | 11.21±7.44 | 1.7±3.14 | 0.09±0.58 |
| Male (n=61) | |||
| Min-max (med) | 0-37.7 (13) | −2.3-13.2 (0.9) | −1.4-5 (0.6) |
| Mean±SD | 13.42±8.69 | 2.14±3.16 | 0.81±1.05 |
| Test value (Z) | −1.145 | −1.246 | −3.788 |
| p-value* | 0.252 | 0.213 | 0.001‡ |
| Smoking | |||
| Nonsmoker (n=40) | |||
| Min-max (med) | 0-37.7 (13.6) | −2.3-10 (0.6) | −1.4-5 (0.4) |
| Mean±SD | 14.51±8.56 | 1.64±2.6 | 0.57±1.05 |
| Smoker (n=60) | |||
| Min-max (med) | −0.8-32.3 (9.6) | −1.5-13.5 (0.5) | −1.4-2.7 (0.4) |
| Mean±SD | 11.26±7.85 | 2.19±3.46 | 0.5±0.91 |
| Test value (Z) | −2.005 | −0.067 | −0.345 |
| p-value* | 0.045† | 0.947 | 0.730 |
| Alcohol consumption | |||
| No (n=72) | |||
| Min-max (med) | −0.8-37.7 (13.1) | −1.5-13.2 (0.9) | −1.4-5 (0.4) |
| Mean±SD | 13.37±8.17 | 2.1±3.03 | 0.58±0.96 |
| Yes (n=28) | |||
| Min-max (med) | 0-31.7 (8.7) | −2.3-13.5 (0.2) | −1.4-2.6 (0.3) |
| Mean±SD | 10.48±8.25 | 1.63±3.45 | 0.4±0.98 |
| Test value (Z) | −1.754 | −1.488 | −0.998 |
| p-value* | 0.079 | 0.137 | 0.318 |
| Accompanying disease | |||
| Absent (n=86) | |||
| Min-max (med) | 0-37.7 (12.9) | −2.3-13.5 (0.9) | −1.4-5 (0.4) |
| Mean±SD | 13±8.45 | 2.23±3.28 | 0.55±0.98 |
| Present (n=14) | |||
| Min-max (med) | −0.8-22.4 (9) | −1.5-4 (0.2) | −1.1-2.4 (0.4) |
| Mean±SD | 9.84±6.52 | 0.36±1.4 | 0.39±0.84 |
| Test value (Z) | −1.113 | −2.353 | −0.397 |
| p-value* | 0.266 | 0.019† | 0.691 |
| Any systemic treatment | |||
| No (n=88) | |||
| Min-max (med) | 0-37.7 (12.9) | −2.3-13.5 (0.9) | −1.4-5 (0.4) |
| Mean±SD | 13.03±8.38 | 2.19±3.25 | 0.56±0.97 |
| Yes (n=12) | |||
| Min-max (med) | −0.8-22.4 (7.7) | −1.5-4 (0.2) | −1.1-2.4 (0.3) |
| Mean±SD | 9.08±6.58 | 0.35±1.45 | 0.31±0.89 |
| Test value (Z) | −1.453 | −2.167 | −0.870 |
| p-value* | 0.146 | 0.030† | 0.384 |
| Nail involvement | |||
| Absent (n=65) | |||
| Min-max (med) | −0.8-37.7 (10.5) | −2.3-10 (0.9) | −1.4-5 (0.4) |
| Mean±SD | 12.53±8.85 | 1.72±2.51 | 0.57±0.99 |
| Present (n=35) | |||
| Min-max (med) | 0-32.3 (13.3) | −2.3-13.5 (0.3) | −1.4-2.7 (0.3) |
| Mean±SD | 12.61±7.15 | 2.44±4.08 | 0.46±0.92 |
| Test value (Z) | −0.520 | −0.308 | −0.463 |
| p-value* | 0.603 | 0.758 | 0.644 |
| Concominant arthritis | −0.8-37.7 (12.8) | −2.3-13.2 (0.5) | −1.4-5 (0.4) |
| Absent (n=87) | 13.05±8.37 | 1.95±3.02 | 0.57±0.97 |
| Min-max (med) | |||
| Mean±SD | |||
| Present (n=13) | 0-22.4 (6.8) | −2.3-13.5 (0.2) | −0.9-2.6 (−0.1) |
| Min-max (med) | 9.3±6.84 | 2.13±4.05 | 0.28±0.93 |
| Mean±SD | |||
| Test value (Z) | −1.456 | −0.462 | −1.415 |
| p-value* | 0.146 | 0.644 | 0.157 |
PASI: Psoriasis Area and Severity Index, CRP: C-reactive protein, NLR: neutrophil-lymphocyte ratio, Min: minimum, max: maximum, med: median, SD: standard deviation. *Mann–Whitney U-test, †p<0.05, ‡p<0.01.